784 filings
Page 16 of 40
4
William Karl Hornung
30 Jan 20
Diffusion Pharmaceuticals / William Karl Hornung ownership change
4:54pm
4
CRVO
CervoMed Inc
13 Jan 20
Diffusion Pharmaceuticals / Robert Joseph Jr. Cobuzzi ownership change
5:11pm
3
CRVO
CervoMed Inc
13 Jan 20
Diffusion Pharmaceuticals / Robert Joseph Jr. Cobuzzi ownership change
5:09pm
8-K
CRVO
CervoMed Inc
13 Jan 20
Diffusion Pharmaceuticals Appoints Life Sciences Veteran Dr. Robert Cobuzzi, Jr. to its Board of Directors
4:16pm
4
CRVO
CervoMed Inc
9 Jan 20
Diffusion Pharmaceuticals / Thomas E Byrne ownership change
5:03pm
SC 13G/A
CRVO
CervoMed Inc
9 Jan 20
Diffusion Pharmaceuticals Inc.
3:46pm
424B3
CRVO
CervoMed Inc
30 Dec 19
Prospectus supplement
10:07am
EFFECT
CRVO
CervoMed Inc
30 Dec 19
Notice of effectiveness
12:15am
UPLOAD
CRVO
CervoMed Inc
23 Dec 19
Letter from SEC
12:00am
CORRESP
CRVO
CervoMed Inc
23 Dec 19
Correspondence with SEC
12:00am
S-1
CRVO
CervoMed Inc
IPO registration
20 Dec 19
5:29pm
SC 13G
Intracoastal Capital, LLC
20 Dec 19
Diffusion Pharmaceuticals Inc.
4:17pm
8-K
CRVO
CervoMed Inc
20 Dec 19
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:08pm
D
CRVO
CervoMed Inc
17 Dec 19
$783.35K in options / securities to be acquired, sold $783.35K, 3 investors
4:45pm
8-K
CRVO
CervoMed Inc
13 Dec 19
Diffusion Pharmaceuticals Inc. Announces $3.5 Million Registered Direct Offering Priced At-the-Market
4:19pm
424B5
CRVO
CervoMed Inc
13 Dec 19
Prospectus supplement for primary offering
7:59am
8-K
CRVO
CervoMed Inc
11 Dec 19
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
3:15pm
8-K
CRVO
CervoMed Inc
10 Dec 19
Presentation Made by Chief Scientific Officer John Gainer at the Inaugural Glioblastoma Drug Development Summit
4:25pm
8-K
CRVO
CervoMed Inc
10 Dec 19
Regulation FD Disclosure
8:44am
SC 13G
CRVO
CervoMed Inc
25 Nov 19
Diffusion Pharmaceuticals Inc.
12:00am